Articles Companion animals

24 July 2026

Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis A Proof-of-Concept Study.

Clinical evidence update from Veterinary dermatology

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Veterinary dermatology in 2026 evaluated efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study..

Key Findings

DNA-based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal-associated membrane protein-1 (LAMP). This proof-of-concept study evaluated the efficacy and safety of a Der f 2/Zen 1-LAMP-based DNA vaccine immunotherapy in client-owned dogs with nonseasonal AD sensitised to Dermatophagoides farinae (Df). Fifteen dogs positive for Df only and 20 dogs with reactivity to additional environmental allergens received either a low (0.5 mg/0.1 mL) or high (2 mg/0.4 mL) dose of the vaccine intradermally. Four doses of vaccine were administered every 2 weeks. Pruritus, Canine Atopic...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis A Proof-of-Concept Study.

Clinical evidence update from Veterinary dermatology

Comments

List

Add

Tag

Related Articles

23 July 2026
Renoprotective effects of curcumin in cats with chronic kidney disease.

Renoprotective effects of curcumin in cats with chronic kidney disease.

23 July 2026
An Open-Label Split-Body Clinical Trial Evaluating Therapeutic Efficacy and Safety of Cold Atmospheric Plasma in Canine Acute Otitis Externa.

An Open-Label Split-Body Clinical Trial Evaluating Therapeutic Efficacy and Safety of Cold Atmospheric Plasma in Canine Acute Otitis Externa.

23 July 2026
Seroprevalence of Q-fever among domestic ruminants, humans and ticks in Ethiopia A systematic review and meta-analysis.

Seroprevalence of Q-fever among domestic ruminants, humans and ticks in Ethiopia A systematic review and meta-analysis.

22 July 2026
The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.

The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.

22 July 2026
Efficacy of Oral Baicalin in Canine Atopic Dermatitis A Randomised Placebo Controlled Trial.

Efficacy of Oral Baicalin in Canine Atopic Dermatitis A Randomised Placebo Controlled Trial.

More news

Heavy rains expected: LSU Vet Med offers tips for pet owners and people who encounter wildlife

Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform

EXPRESS Comparing the Efficacy of Transmucosal and Subcutaneous Glucagon Administration in Response to Insulin-Induced Hypoglycemia in Healthy Cats.

Efficacy of Therapeutic UVC Irradiation in Reducing Bacterial Load in Microbial Keratitis A Retrospective Clinical Study in Veterinary Patients.

Welcome Dr. JeanMarie Cavillo, microbiologist, Washington Animal Disease Diagnostic Laboratory

Newsletter